Acetadote - News Articles

Repeated Acetaminophen Can Cause Infant Liver Failure - In case study, intravenous N-acetylcysteine therapy improved child's clinical condition - ModernMedicine


The child's clinical condition and laboratory test results improved rapidly after intravenous N-acetylcysteine therapy. "Health care providers should be aware that multiple doses of acetaminophen in infants may lead to acute hepatic failure. N -acetylcysteine therapy should be ...
Drug Offers No CIN Protection - Renal and Urology News


CHICAGO—Brazilian researchers report that acetylcysteine should no longer be used to prevent contrast-induced nephropathy (CIN) in patients undergoing coronary and vascular angiography. At the American Heart Association Scientific Sessions 2010, the investigators presented data from the 2,308-patient ...
Pre-Market NASDAQ Movers (CPIX, COCO, ICGN, KLAC, AMAT, CSTR, KNDI, HAS, ARMH, QGEN) - International Business Times


Upon receipt of initial marketing approval for Acetadote, the company made a commitment for a phase IV study to develop new formulation with less side effects. Accordingly, Cumberland has initiated a program for the purpose. Must Read 18 and Counting: Political and Social Unrest ...
Jefferies Remains Cautious On Cumberland Pharma | Benzinga.com


By Benzinga Staff Jefferies remains cautious on shares of Cumberland Pharma (NASDAQ: CPIX) as Acetadote's orphan drug exclusivity expires this weekend (Jan 23). If the product were to go generic, profitability would be a challenge with still negligible Caldolor sales. Acetadote ...
Am J Physiol Cell Physiol -- Sign In Page


by treatment with the antioxidant N-acetylcysteine, indicating a potential role for ceramide-mediated oxidant signaling in promoting muscle weakness. ...
Side effects of Acetadote - by Dr Pandula Siribaddana - Helium


Acetadote is a brand of drug which contains the active ingredient Acetylcysteine and is used as an antedote (and thus the name) for overdosing following ingestions of Acetaminophen. Thus, Acetadote will protect the liver from acetaminophen but in order for it ...
Inhibition of IFN-gamma-dependent antiviral airway epithelial defense by cigarette smoke - 7thSpace Interactive


and inhibition of RSV infection were decreased by glutathione augmentation of epithelial cells using N-acetylcysteine or glutathione monoethyl ester, providing one strategy to alter cigarette smoke effects. Conclusions: The results indicate that CSE inhibits the antiviral effects ...
FDA questions claims in Cumberland Pharmaceuticals brochure | tennessean.com | The Tennessean

Nashville Post (subscription)
related to a marketing brochure that the regulator says makes unsubstantiated claims and minimizes risk associated with its Acetadote injection. ...
Post Cancer: Boost Your Immune System Part 2 | EmpowHER - Women's Health Online


During the cooking process, chicken releases the amino acid cysteine which chemically resembles the bronchitis drug acetylcysteine. ...
Evidence based guidelines for complex regional pain syndrome type 1. - 7thSpace Interactive


For inflammatory symptoms, free-radical scavengers (dimethylsulphoxide or acetylcysteine) are advised. To promote peripheral blood flow, vasodilatory medication may be considered. Percutaneous sympathetic blockades may be used to increase blood flow in case ...
Effects of N-acetylcysteine on renal dysfunction in neonates undergoing the arterial switch operation -- Aiyagari et al. 139 (4): 956 -- The Journal of Thoracic and Cardiovascular Surgery


Objective: We evaluated N-acetylcysteine, a potent antioxidant, as prevention for renal dysfunction in infants undergoing cardiac surgery for ...
Cumberland ??Acetadote?sNDA_??_???


(CPIX) 11.24 : Cumberland Pharma??,???FDA??????????(sNDA),??Acetadote?????????????????,Cumberland?2004? ??Acetadote,????????????????????(acetaminophen overdose)???? ????:???????????,????????????????????????????,?????????????????????????????????????????,???????,??????????? ...
PR-CANADA.net - Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results


This growth was due primarily to an increase in volume for Acetadote® (acetylcysteine) Injection, the Company's treatment for acetaminophen overdose, as well as initial stocking from the launch of Caldolor® (ibuprofen) Injection, Cumberland's recently approved IV treatment for pain ...
RxNews Recap for Tuesday 03-30-10. Myriad Genetics denied gene patent. After the bell Depomed submits NDA. - BioMedReports.com


Acetadote was launched by Cumberland in 2004 as the first US-approved injectable drug to treat acetaminophen overdose. The sNDA includes data from a clinical trial led by investigators at the University of Texas Southwestern Medical Center indicating that acute liver failure patients ...
Looking for a District of Columbia Acetadote lawyer? Get in touch with one of our District of Columbia Acetadote lawyers now.

Need An Acetadote Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for a District of Columbia Acetadote lawyer? Get in touch with one of our District of Columbia Acetadote lawyers now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Acetadote Case - Submit Your Information Below

Do you need legal assistance with your Acetadote case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Acetadote Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.